Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Fei Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6767-3283; OpenAlex author ID A5100455725. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Retraction Note: hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Co-author DOI 10.1038/s41416-025-03268-y↗
  2. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer. First author DOI 10.1002/ijc.29070↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Miao Yi · 1 shared paper, 2025 · strength 0.24
  2. Jia Wei · 1 shared paper, 2025 · strength 0.24
  3. Xiaofeng Xue · 1 shared paper, 2025 · strength 0.24
  4. Jie J. Yao · 1 shared paper, 2025 · strength 0.24
  5. Yujuan Zhang · 1 shared paper, 2015 · strength 0.05
  6. Ting Zhan · 1 shared paper, 2015 · strength 0.05
  7. Wei Cui · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.